Analytical Development Including High-Throughput Screening Assays, Quality Control (QC) Testing, And ICH Stability Studies
Source: OmniaBio
CCRM offers analytical assay development for cell and gene therapies. We have developed assays for immunotherapies (autologous and allogeneic) and viral vectors, as well as high-throughput screening assays.
Immunotherapy
- Potency by cytokine release and quantitation
- Purity and identity by flow cytometry
- Cell counting and viability
Viral Vector
- Infectious titre by flow cytometry
- Infectious genome and vector genome titres by ddPCR
- Physical titre by ELISA
- Residual host cell protein quantitation
- Residual host DNA quantitation
High-throughput Screening Assays
- Hamilton Vantage and Nimbus liquid handling
This website uses cookies to ensure you get the best experience on our website. Learn more